Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 32 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 9562237

    Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  2. US 9550818

    Methods for use of vascular endothelial growth factor antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  3. US 9550742

    11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  4. US 9539220

    Methods for treating suicidal ideation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  5. US 9540471

    Nitric oxide-releasing diazeniumdiolated polyvinylpyrrolidone-based polymers, and compositions, medical devices, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  6. US 9540415

    Inhibitors of the farnesoid X receptor and uses in medicine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  7. US 9540427

    Peptide-based stat inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  8. US 9532989

    Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  9. US 9534041

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  10. US 9526739

    Compositions and methods to treat cardiac diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  11. US 9527903

    Engineered antibody constant domain molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  12. US 9522871

    Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  13. US 9522955

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  14. US 9522948

    GP100-specific T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  15. US 9518080

    Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  16. US 9517243

    Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  17. US 9517224

    Methods of treating patients infected with HIV and HTLV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  18. US 9511103

    AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  19. US 9506032

    Engineered biological pacemakers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

  20. US 9504729

    Antiangiogenic small molecules and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

  21. US 9498511

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  22. US 9499821

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  23. US 9492405

    Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  24. US 9492439

    Amido compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.